| New anticancer agents: recent developments in tumor therapy R Ali, Z Mirza, GMD Ashraf, MA Kamal, SA Ansari, GA Damanhouri, ... Anticancer research 32 (7), 2999-3005, 2012 | 205 | 2012 |
| Nanoparticles-based drug delivery and gene therapy for breast cancer: Recent advancements and future challenges Z Mirza, S Karim Seminars in cancer biology 69, 226-237, 2021 | 134 | 2021 |
| Isolation, characterization, and effect of phosphate-zinc-solubilizing bacterial strains on chickpea (Cicer arietinum L.) growth A Zaheer, A Malik, A Sher, MM Qaisrani, A Mehmood, SU Khan, M Ashraf, ... Saudi journal of biological sciences 26 (5), 1061-1067, 2019 | 103 | 2019 |
| Conotoxins: Structure, therapeutic potential and pharmacological applications R Mir, S Karim, M Amjad Kamal, C M Wilson, Z Mirza Current pharmaceutical design 22 (5), 582-589, 2016 | 71 | 2016 |
| Comprehensive survey of HRAS, KRAS, and NRAS mutations in proliferative thyroid lesions from an ethnically diverse population HJ Schulten, S Salama, A Al-Ahmadi, Z Al-Mansouri, Z Mirza, ... Anticancer research 33 (11), 4779-4784, 2013 | 58 | 2013 |
| Impact of S100A8 expression on kidney cancer progression and molecular docking studies for kidney cancer therapeutics Z Mirza, HJ Schulten, HM Farsi, JA Al-Maghrabi, MA Gari, AG Chaudhary, ... Anticancer research 34 (4), 1873-1884, 2014 | 52 | 2014 |
| Establishing genomic/transcriptomic links between Alzheimer’s disease and type 2 diabetes mellitus by meta-analysis approach Z Mirza, M A Kamal, M H Al-Qahtani, S Karim CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2014 | 46 | 2014 |
| Proteomics approaches to understand linkage between Alzheimer’s disease and type 2 diabetes mellitus Z Mirza, A Ali, G Md Ashraf, M A Kamal, A M Abuzenadah, A G Choudhary, ... CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2014 | 46 | 2014 |
| Design and delivery of therapeutic siRNAs: application to MERS-coronavirus SS Sohrab, SA El-Kafrawy, Z Mirza, MA Kamal, EI Azhar Current pharmaceutical design 24 (1), 62-77, 2018 | 45 | 2018 |
| Panacea seed “Nigella”: A review focusing on regenerative effects for gastric ailments SA Khan, AM Khan, S Karim, MA Kamal, GA Damanhouri, Z Mirza Saudi Journal of Biological Sciences 23 (4), 542-553, 2016 | 42 | 2016 |
| The role of viruses in neurodegenerative and neurobehavioral diseases S Karim, Z Mirza, M A Kamal, A M Abuzenadah, E I Azhar, M H Al-Qahtani, ... CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2014 | 37 | 2014 |
| Cyclin D1 as a therapeutic target of renal cell carcinoma-a combined transcriptomics, tissue microarray and molecular docking study from the Kingdom of Saudi Arabia S Karim, JA Al-Maghrabi, HMA Farsi, AJ Al-Sayyad, HJ Schulten, ... BMC cancer 16, 9-21, 2016 | 35 | 2016 |
| A comparative study of bacterial diversity based on culturable and culture-independent techniques in the rhizosphere of maize (Zea mays L.) MM Qaisrani, A Zaheer, MS Mirza, T Naqqash, TB Qaisrani, MK Hanif, ... Saudi journal of biological sciences 26 (7), 1344-1351, 2019 | 33 | 2019 |
| Implications of advanced oxidation protein products (AOPPs), advanced glycation end products (AGEs) and other biomarkers in the development of cardiovascular diseases M Rasool, A Malik, TT Butt, MAB Ashraf, R Rasool, A Zahid, S Waquar, ... Saudi journal of biological sciences 26 (2), 334-339, 2019 | 32 | 2019 |
| Genomic answers for recurrent spontaneous abortion in Saudi Arabia: an array comparative genomic hybridization approach S Karim, HS Jamal, A Rouzi, MSM Ardawi, HJ Schulten, Z Mirza, ... Reproductive Biology 17 (2), 133-143, 2017 | 32 | 2017 |
| Advancements in CRISPR/Cas9 technology—focusing on cancer therapeutics and beyond Z Mirza, S Karim Seminars in Cell & Developmental Biology 96, 13-21, 2019 | 29 | 2019 |
| An association of virus infection with type 2 diabetes and Alzheimer’s disease S Karim, Z Mirza, M A Kamal, A M Abuzenadah, E I Azhar, M H Al-Qahtani, ... CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2014 | 27 | 2014 |
| Molecular interaction of a kinase inhibitor midostaurin with anticancer drug targets, S100A8 and EGFR: transcriptional profiling and molecular docking study for kidney cancer … Z Mirza, HJ Schulten, HM Farsi, JA Al-Maghrabi, MA Gari, AG Chaudhary, ... PLoS One 10 (3), e0119765, 2015 | 24 | 2015 |
| Low expression of leptin and its association with breast cancer: A transcriptomic study S Karim, A Merdad, HJ Schulten, M Jayapal, A Dallol, A Buhmeida, ... Oncology reports 36 (1), 43-48, 2016 | 21 | 2016 |
| Transcriptomics study of neurodegenerative disease: emphasis on synaptic dysfunction mechanism in Alzheimer’s disease S Karim, Z Mirza, S A Ansari, M Rasool, Z Iqbal, S S Sohrab, M A Kamal, ... CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2014 | 20 | 2014 |
